Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-3-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9343
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
319-20
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7872356-AIDS-Related Opportunistic Infections,
pubmed-meshheading:7872356-Clinical Trials as Topic,
pubmed-meshheading:7872356-Cytomegalovirus Retinitis,
pubmed-meshheading:7872356-Foscarnet,
pubmed-meshheading:7872356-Ganciclovir,
pubmed-meshheading:7872356-Humans,
pubmed-meshheading:7872356-Treatment Outcome
|
pubmed:year |
1995
|
pubmed:articleTitle |
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis.
|
pubmed:publicationType |
Letter,
Clinical Trial,
Comment,
Randomized Controlled Trial
|